Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
Frontiers of Medicine ; (4): 649-656, 2021.
Article in English | WPRIM | ID: wpr-922500

ABSTRACT

Tumorigenesis involves metabolic reprogramming and abnormal lipid metabolism, which is manifested by increased endogenous fat mobilization, hypertriglyceridemia, and increased fatty acid synthesis. Fatty acid synthase (FASN) is a key enzyme for the de novo synthesis of fatty acids, and monoacylglycerol esterase (MGLL) is an important metabolic enzyme that converts triglycerides into free fatty acids. Both enzymes play an important role in lipid metabolism and are associated with tumor-related signaling pathways, the most common of which is the PI3K-AKT signaling pathway. They can also regulate the immune microenvironment, participate in epithelial-mesenchymal transition, and then regulate tumor invasion and metastasis. Current literature have shown that these two genes are abnormally expressed in many types of tumors and are highly correlated with tumor migration and invasion. This article introduces the structures and functions of FASN and MGLL, their relationship with abnormal lipid metabolism, and the mechanism of the regulation of tumor invasion and metastasis and reviews the research progress of the relationship of FASN and MGLL with tumor invasion and metastasis.


Subject(s)
Humans , Cell Line, Tumor , Fatty Acid Synthase, Type I/metabolism , Lipid Metabolism , Monoacylglycerol Lipases/metabolism , Neoplasms , Phosphatidylinositol 3-Kinases , Signal Transduction , Tumor Microenvironment
2.
Rev. bras. pesqui. méd. biol ; Braz. j. med. biol. res;50(5): e5858, 2017. tab, graf
Article in English | LILACS | ID: biblio-839295

ABSTRACT

Modifications in life-style and/or pharmacotherapies contribute to weight loss and ameliorate the metabolic profile of diet-induced obese humans and rodents. Since these strategies fail to treat hypothalamic obesity, we have assessed the possible mechanisms by which duodenal-jejunal bypass (DJB) surgery regulates hepatic lipid metabolism and the morphophysiology of pancreatic islets, in hypothalamic obese (HyO) rats. During the first 5 days of life, male Wistar rats received subcutaneous injections of monosodium glutamate (4 g/kg body weight, HyO group), or saline (CTL). At 90 days of age, HyO rats were randomly subjected to DJB (HyO DJB group) or sham surgery (HyO Sham group). HyO Sham rats were morbidly obese, insulin resistant, hypertriglyceridemic and displayed higher serum concentrations of non-esterified fatty acids (NEFA) and hepatic triglyceride (TG). These effects were associated with higher expressions of the lipogenic genes and fatty acid synthase (FASN) protein content in the liver. Furthermore, hepatic genes involved in β-oxidation and TG export were down-regulated in HyO rats. In addition, these rats exhibited hyperinsulinemia, β-cell hypersecretion, a higher percentage of islets and β-cell area/pancreas section, and enhanced nuclear content of Ki67 protein in islet-cells. At 2 months after DJB surgery, serum concentrations of TG and NEFA, but not hepatic TG accumulation and gene and protein expressions, were normalized in HyO rats. Insulin release and Ki67 positive cells were also normalized in HyO DJB islets. In conclusion, DJB decreased islet-cell proliferation, normalized insulinemia, and ameliorated insulin sensitivity and plasma lipid profile, independently of changes in hepatic metabolism.


Subject(s)
Animals , Male , Duodenum/surgery , Fatty Liver/metabolism , Gastric Bypass/methods , Hypothalamic Diseases/metabolism , Islets of Langerhans/cytology , Islets of Langerhans/metabolism , Jejunum/surgery , Obesity/metabolism , Animals, Newborn , Blood Glucose/metabolism , Cell Proliferation , Cholesterol/blood , Fatty Acid Synthase, Type I/metabolism , Fatty Acids/blood , Fatty Liver/physiopathology , Hypothalamic Diseases/physiopathology , Hypothalamic Diseases/surgery , Insulin Resistance , Insulin/metabolism , Islets of Langerhans/physiopathology , Lipogenesis/genetics , Liver/metabolism , Liver/pathology , Obesity/physiopathology , Obesity/surgery , Pancreas/metabolism , Pancreas/pathology , Random Allocation , Rats, Wistar , Reproducibility of Results , Time Factors , Triglycerides/blood
SELECTION OF CITATIONS
SEARCH DETAIL